close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:AIMI)

0.0711 UNCHANGED
Last Price Updated: 1:14 PM EDT, Jun 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AIMI

AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
From AIM ImmunoTech Inc.
Via GlobeNewswire
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
From AIM ImmunoTech Inc.
Via GlobeNewswire
AIM ImmunoTech Resumes Trading on NYSE American
Company trading under the ticker “AIM” NYSE American effective at the start of trading today, Tuesday, June 17th 
From AIM ImmunoTech Inc.
Via GlobeNewswire
AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
From AIM ImmunoTech Inc.
Via GlobeNewswire
AIM ImmunoTech Announces NYSE American Removal of Trading Suspension
Company expected to resume trading on the NYSE American on Tuesday, June 17, 2025 
From AIM ImmunoTech Inc.
Via GlobeNewswire
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
From AIM ImmunoTech Inc.
Via GlobeNewswire
AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists
From AIM ImmunoTech Inc.
Via GlobeNewswire
AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
From AIM ImmunoTech Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today